Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

This study has been withdrawn prior to enrollment.
(Change in research focus)
Caring for Carcinoid Foundation
GI Cancer Research Gift Fund
Information provided by (Responsible Party):
Stanford University Identifier:
First received: December 10, 2009
Last updated: May 24, 2012
Last verified: May 2012

We have an active research program in gastrointestinal cancers including clinical trials, epidemiologic, and translational studies. We would like to establish a biospecimen bank linked to useful clinical information in order to learn more about diagnostic, predictive and prognostic markers for gastrointestinal cancers.


1. To collect and store tumor and normal tissue (previously collected paraffin embedded or frozen specimen) and blood in patients with gastrointestinal (GI) cancers.


  1. Collect detailed clinical information via a patient questionnaire that includes demographic, socioeconomic, lifestyle, family, past medical, medication and cancer histories
  2. Collect details about the tumor specimen extracted from patient charts.

Condition Intervention
Gastrointestinal Neoplasms
Gynecologic Cancers
Gynecologic Cancers Cervical Cancer
Gastric (Stomach) Cancer
Gastro-Esophageal(GE) Junction Cancer
Gastrointenstinal Stromal Tumor (GIST)
Colon/Rectal Cancer
Colon/Rectal Cancer Colon Cancer
Colon/Rectal Cancer Rectal Cancer
Colon/Rectal Cancer Anal Cancer
Anal Cancer
Hepatobiliary Cancers
Hepatobiliary Cancers Liver
Pancreatic Cancer
Procedure: Blood Draw
Procedure: Frozen Tumor Specimens

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Collection of Biospecimen and Clinical Information in Patients With Gastrointestinal Cancers

Resource links provided by NLM:

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • None: Biospecimen will be collected for future research.

Biospecimen Retention:   Samples Without DNA
This study requires that we obtain archived tumor and normal tissue and blood.

Enrollment: 0
Study Start Date: January 2010
Estimated Study Completion Date: January 2099
Estimated Primary Completion Date: January 2099 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with gastrointestinal cancer.

Inclusion Criteria:1. Patients are eligible if they have a histologically proven gastrointestinal cancer (esophageal, gastroesophageal junction, gastric, small intestine, appendix, colon, rectum, anus, liver, gallbladder, bile ducts, pancreas, neuroendocrine, and GI stromal tumor).

2. 18 years of age or older

3. Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:None

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01031056

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Caring for Carcinoid Foundation
GI Cancer Research Gift Fund
Principal Investigator: Teri A Longacre M.D. Stanford University
  More Information

Responsible Party: Stanford University Identifier: NCT01031056     History of Changes
Other Study ID Numbers: SU-09092009-3840
Study First Received: December 10, 2009
Last Updated: May 24, 2012

Additional relevant MeSH terms:
Pancreatic Neoplasms
Rectal Neoplasms
Uterine Cervical Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Anus Neoplasms
Colorectal Neoplasms
Neoplasms by Site
Endocrine Gland Neoplasms
Digestive System Diseases
Pancreatic Diseases
Endocrine System Diseases
Intestinal Neoplasms
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female
Anus Diseases
Colonic Diseases processed this record on April 21, 2017